Judit Füvesi: Influence Statistics

Judit Füvesi

Judit Füvesi

Albert Szent-Györgyi Clinical Centre, Department of Neurology, Faculty of General Medicine, University of Szeged, 6725 Szeged, Hungary;, biernacki.tamas@med.u-szeged.hu, ...

Judit Füvesi: Expert Impact

Concepts for which Judit Füvesi has direct influence: Multiple sclerosis , Csongrád county , Hungarian patients , Cognitive impairment , Life multiple sclerosis , Fatigue depression , Kynurenic acid .

Judit Füvesi: KOL impact

Concepts related to the work of other authors for which for which Judit Füvesi has influence: Multiple sclerosis , Kynurenic acid , Cognitive impairment , Kynurenine pathway , Processing speed , Biogenic amines , Fatigue depression .

KOL Resume for Judit Füvesi

Year
2022

Albert Szent-Györgyi Clinical Centre, Department of Neurology, Faculty of General Medicine, University of Szeged, 6725 Szeged, Hungary;, (T.B.);, (Z.K.);, (D.S.);, (J.F.);, (Z.F.-N.);, (P.F.);, (T.Z.K.);, (P.K.);, (K.B.)

2020

Department of Neurology, Faculty of General Medicine, Albert Szent‐Györgyi Clinical Centre, University of Szeged, Szeged, Hungary

2019

Szegedi Tudományegyetem, ÁOK, Neurológiai Klinika, Szeged.

2018

Szegedi Tudományegyetem, Neurológiai Klinika, Szeged.

2017

Department of Neurology, Faculty of General Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Semmelweis u 6., H-6725 Szeged, Hungary

Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ, Neurológiai Klinika, Szeged.

2016

Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, 6 Semmelweis Str., 6725 Szeged, Hungary

2015

Department of Neurology, Faculty of General Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary

2014

Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary

2012

Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Semmelweis u. 6, 6725, Szeged, Hungary

2010

Department of Neurology, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary

2009

Department of Neurology, Albert Szent-Györgyi Clinical Centre, University of Szeged, 6 Semmelweis u., H-6725, Szeged, Hungary

2008

Department of Neurology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Szeged

2007

Department of Neurology, Albert Szent-Gyögyi Medical and Pharmaceutical Centre, University of Szeged, Hungary

2006

Department of Neurology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Semmelweis u. 6., H-6725 Szeged, Hungary

2004

Department of Neurology, University of Szeged, P.O. Box 71, H-6701 Szeged, Hungary

2001

Department of Neurology, Faculty of General Medicine, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Hungary

Prominent publications by Judit Füvesi

KOL-Index: 15526 . BACKGROUND: The common symptoms of multiple sclerosis are fatigue, depression, cognitive dysfunction, pain and sexual dysfunction, which influence the health-related quality of life of the patients. OBJECTIVE: We aimed to determine the correlations between the health-related quality of life, the level of disability, fatigue and depression in glatiramer acetate-treated patients with ...
Known for Multiple Sclerosis | Fatigue Depression | Glatiramer Acetate | Quality Life
KOL-Index: 10763 . BACKGROUND: Multiple Sclerosis (MS) causes not only somatic, but also cognitive impairment regardless of the patients׳ age or the course of the disease. The Brief International Cognitive Assessment for MS (BICAMS) test, published in 2011, is a short cognitive questionnaire: a fast, reliable, sensitive and specific tool for the evaluation of the patients׳ cognitive state. OBJECTIVES: Our ...
Known for Multiple Sclerosis | Cognitive Impairment | Bicams Test | Quality Life
KOL-Index: 6762 . OBJECTIVE: The aim of this study was to determine the prevalence of multiple sclerosis (MS) in the population of Csongrád County, Hungary (400,128 inhabitants) and to determine the functional status (based on the Expanded Disability Status Scale; EDSS) of the patients according to the clinical forms of the disease. METHODS: The diagnosis was established with the aid of the Poser diagnostic ...
Known for Csongrád County | Multiple Sclerosis | Clinical Forms | Relapsing Remitting
KOL-Index: 6180 . Health-related quality of life measurements are gaining more importance in the study and clinical practice of multiple sclerosis. The aim of our study was the adaptation of the Multiple Sclerosis Quality of Life Instrument (MSQOL-54) in Hungarian. The study was carried out at the Department of Neurology, University of Szeged and two other multiple sclerosis centers. The Hungarian ...
Known for Multiple Sclerosis | Quality Life | Msqol54 Instrument | Hungarian Version
KOL-Index: 6106 . BACKGROUND: Health-related quality of life (HRQoL) is lower in people with multiple sclerosis (PwMS) compared to the healthy population, psychological symptoms accompanying multiple sclerosis (MS) have a serious impact on the HRQoL of PwMS. Data regarding the subject, however, remain conflicting. OBJECTIVES: To evaluate the patients' sociodemographic attributes, education, fatigue, ...
Known for Multiple Sclerosis | Fatigue Depression | Cognitive Impairment | Quality Life
KOL-Index: 6099 . Kynurenic acid (KYNA) is the only known endogenous N-methyl-D-aspartate (NMDA) receptor inhibitor and might therefore come into consideration as a therapeutic agent in certain neurobiological disorders. However, its use as a neuroprotective compound is practically excluded because KYNA does not readily cross the blood-brain barrier (BBB). We recently synthetized a new compound, ...
Known for Kynurenic Acid | Bbb Kyna | Therapeutic Agent | Bloodbrain Barrier
KOL-Index: 5638 . Tryptophan is one of the essential amino acids, 80% of which is catabolised in the extrahepatic tissues by indoleamine-2,3-dioxygenase (IDO), the rate-limiting enzyme of the kynurenine pathway. Metabolites along the kynurenine pathway have been implicated to play a role in the pathomechanism of neuroinflammatory and neurodegenerative disorders. Changes in the concentration levels of ...
Known for Multiple Sclerosis | Kynurenine Pathway | Amyotrophic Lateral | Neurodegenerative Diseases
KOL-Index: 5365 . Tumour necrosis factor alpha (TNF-alpha) is associated with clinical activity in relapsing-remitting multiple sclerosis (RRMS) and the development of progressive disease. Our aim was to investigate the TNF-alpha -376 polymorphism in primary progressive MS (PPMS) patients. Polymerase chain reaction and restriction fragment length polymorphism were carried out on 45 PPMS patients, 45 age and ...
Known for Multiple Sclerosis | Necrosis Factor | Alpha Gene | Primary Progressive
KOL-Index: 5049 . PRINCIPLES: Apolipoprotein E (ApoE), an important glycoprotein in the transport, uptake and redistribution of cholesterol, is necessary in nerve tissue repair. The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE ε4 allele and Alzheimer's disease. Multiple sclerosis (MS) is a chronic inflammatory neurological disease. The ...
Known for Primary Progressive | Ε2 Allele | Apoe Gene | Multiple Sclerosis
KOL-Index: 4653 . OBJECTIVE: Recent epidemiological studies were mainly based on the Poser or other diagnostic criteria. There have been no previous data from Hungary, which were assessed with the more up-to-date McDonald criteria and which give comparable standardized data from the region. MATERIALS AND METHODS: Data were collected from the MS Register of the Department of Neurology at the University of ...
Known for Multiple Sclerosis | Csongrád County | Central Europe | Clinically Isolated Syndrome
KOL-Index: 4651 . BACKGROUND: The 'Multiple Sclerosis Quality of Life Instrument' (MSQOL-54) was recently validated in Hungarian, on more than 400 multiple sclerosis (MS) patients. The aim of the present study was to examine the impact on their overall quality of life (QoL) of the demographic and clinical data on these patients, and their scores on different QoL scales. METHODS: The Hungarian version of ...
Known for Sclerosis Patients | Life Qol | Healthrelated Quality | Mental Health
KOL-Index: 3507 . OBJECTIVE: We aimed to assess the causes of death, the mortality and survival time of MS patients in Hungary. PATIENTS AND METHODS: Between 1993 and 2013, 740 patients (10,303person-years) were treated at our Outpatients' Clinic, of which 121 died. The causes of death were established from the pathological records or the medical certificates of the cause of death. The standardized ...
Known for Multiple Sclerosis | Primary Progressive | Death Smr | Sex Factors
KOL-Index: 3136 . Multiple Sclerosis (MS) is a chronic disease, but in rare fulminant cases rapid progression may lead to death shortly after diagnosis. Currently there is no diagnostic test to predict disease course. The aim of this study was to identify potential biomarkers/proteins related to rapid progression. We present the case history of a 15-year-old male MS patient. Cerebrospinal fluid (CSF) was ...
Known for Cerebrospinal Fluid | Proteomic Analysis | Multiple Sclerosis | Csf Samples
KOL-Index: 3074 . The prevalence of familial aggregation of multiple sclerosis (MS) is estimated between 5 and 10%. Studies emphasize the effect of genetic factors over the environment of the patients in the development of the disease. We investigated familial accumulation of MS in the cases of 1500 patients in five Hungarian MS centers. According to our data, the risk of familial MS in Hungary is lower ...
Known for Multiple Sclerosis | Prevalence Familial | Genetic Predisposition
KOL-Index: 2985 . OBJECTIVES: Not so long ago, a novel phenotypic classification of multiple sclerosis (MS) and revisions to the McDonald diagnostic criteria were published. Good quality, standardized, and therefore comparable epidemiological data from the Central European region altogether are scarce, and data based on the aforementioned criteria are nonexistent; thus, an update is needed. MATERIALS AND ...
Known for Multiple Sclerosis | Prevalence Hungary | Female Male | Phenotypic Classification

Key People For Multiple Sclerosis

Top KOLs in the world
#1
Alanda K Thompson
multiple sclerosis spinal cord magnetic resonance
#2
Chris H Polman
multiple sclerosis magnetic resonance spinal cord
#3
Fred D Lublin
multiple sclerosis glatiramer acetate monoclonal antibodies
#4
Ludwig Kappos
multiple sclerosis disability progression magnetic resonance
#5
Massimo Filippi
multiple sclerosis magnetic resonance cervical cord
#6
Hans‐Peter Hartung
multiple sclerosis chronic inflammatory schwann cells

Albert Szent-Györgyi Clinical Centre, Department of Neurology, Faculty of General Medicine, University of Szeged, 6725 Szeged, Hungary;, biernacki.tamas@med.u-szeged.hu, (T.B.);, zsofia.kokas@med.u-szeged.huzsiofia, (Z.K.);, sandi.daniel@med.u-szeged